Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.70B | 2.46B | 2.28B | 2.11B | 1.76B | 1.83B | Gross Profit |
805.80M | 778.60M | 2.03B | 1.88B | 1.58B | 1.64B | EBIT |
668.60M | 401.80M | 467.20M | 379.20M | 286.20M | 295.10M | EBITDA |
585.90M | 357.80M | 591.30M | 454.60M | 415.40M | 325.10M | Net Income Common Stockholders |
6.20M | 12.90M | 291.20M | 190.50M | 172.60M | 127.80M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
299.90M | 299.90M | 179.60M | 122.80M | 168.60M | 424.40M | Total Assets |
3.70B | 3.70B | 3.33B | 2.84B | 2.48B | 2.93B | Total Debt |
1.87B | 1.87B | 1.45B | 1.24B | 967.70M | 1.45B | Net Debt |
1.57B | 1.57B | 1.27B | 1.11B | 799.10M | 1.02B | Total Liabilities |
2.50B | 2.50B | 1.95B | 1.71B | 1.40B | 1.82B | Stockholders Equity |
1.18B | 1.18B | 1.37B | 1.12B | 1.07B | 1.10B |
Cash Flow | Free Cash Flow | ||||
233.90M | 198.40M | 293.80M | 167.90M | 184.70M | 137.90M | Operating Cash Flow |
374.80M | 350.10M | 439.90M | 286.80M | 265.80M | 259.00M | Investing Cash Flow |
-334.30M | -235.90M | -267.00M | -405.90M | -124.70M | -166.30M | Financing Cash Flow |
28.70M | -3.10M | -121.20M | 77.40M | -379.90M | 172.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
66 Neutral | $4.50B | 12.28 | 5.32% | 248.52% | 4.13% | -12.36% | |
56 Neutral | $8.32B | 31.07 | 21.29% | 2.31% | 17.15% | -97.70% | |
€2.34B | 50.60 | 3.35% | 3.96% | ― | ― | ||
€981.39M | 20.96 | 15.97% | 4.13% | ― | ― | ||
€742.24M | 10.59 | 18.01% | 5.98% | ― | ― | ||
74 Outperform | AU$1.55B | 20.01 | 9.50% | 1.64% | -1.30% | -7.78% | |
68 Neutral | AU$4.08B | 18.88 | 36.67% | 4.11% | 7.56% | 16.00% |
ALS Limited reports that recent global market volatility and tariff announcements have not materially impacted their input costs. The company maintains flexibility in its operations and remains focused on its value creation framework. For the fiscal year ending March 2025, ALS anticipates an underlying net profit after tax between AUD $310-$313 million. The Minerals division in Commodities has seen a positive turnaround in sample volumes, while the Environmental division in Life Sciences achieved 10% organic growth. Recent acquisitions are integrating ahead of expectations, and the Food and Pharma divisions are under new leadership.
ALS Limited has appointed Catharine Farrow as an independent Non-Executive Director, effective March 24, 2025. Farrow’s extensive experience in the mining industry, including her focus on innovation and technology, aligns with ALS’s strategic priorities and enhances the board’s understanding of its major customers’ needs.